Annals of Colorectal Research

Published by: Kowsar

Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems

Modesto J Varas Lorenzo 1 , 2 , 3 , Fernando Munoz Agel ORCID 1 , 2 , Ramon Abad Belando 2 and Elena Sanchez-Vizcaino Mengual ORCID 4 , *
Authors Information
1 Echoendoscopy Unit and Department of Gastroenterology, Teknon Medical Center, Barcelona, Spain
2 Echoendoscopy Unit and Department of Gastroenterology, Hospital Sanitas CIMA, Barcelona, Spain
3 Facultat de Ciencias de la Salud, Universitat Oberta de Catalunya (UOC), Barcelona, Spain
4 PMO, i2e3 Biomedical Research Institute, Barcelona, Spain
Article information
  • Annals of Colorectal Research: June 30, 2019, 7 (2); e88004
  • Published Online: July 16, 2019
  • Article Type: Research Article
  • Received: December 20, 2018
  • Revised: June 16, 2019
  • Accepted: July 2, 2019
  • DOI: 10.5812/acr.88004

How to Cite: Varas Lorenzo M J, Munoz Agel F, Abad Belando R, Sanchez-Vizcaino Mengual E. Prevalence of Neuroendocrine Tumors in the Gastrointestinal and Hepatobiliary Systems, Ann Colorectal Res. 2019 ; 7(2):e88004. doi: 10.5812/acr.88004.

Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Oberndorfer S. Karzinoide tumoren des dünndarms. 1. Frankf Z Pathol; 1907. p. 425-32. German.
  • 2. Sanders RJ. Carcinoids of the gastrointestinal tract. Surg Gynecol Obstet. 1964;119:369-80.
  • 3. Macdonald RA. A study of 356 carcinoids of the gastrointestinal tract; report of four new cases of the carcinoid syndrome. Am J Med. 1956;21(6):867-78. doi: 10.1016/0002-9343(56)90101-2. [PubMed: 13372563].
  • 4. Buchanan KD, Johnston CF, O'Hare MMT, Ardill JES, Shaw C, Collins JSA, et al. Neuroendocrine tumors: A European view. Am J Med. 1986;81(6):14-22. doi: 10.1016/0002-9343(86)90581-4.
  • 5. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden. Cancer. 2001;92(8):2204-10. doi: 10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>;2-r. [PubMed: 11596039].
  • 6. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand A. 1976;84(4):322-30. [PubMed: 961424].
  • 7. Clemente C, Puig V, Mirada A. [Carcinoid tumor Analysis of 131 cases]. Rev Clin Esp. 1994;194:291-3. Spanish.
  • 8. Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975;36(2):560-9. doi: 10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>;2-4. [PubMed: 1157019].
  • 9. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813-29. doi: 10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>;2-2. [PubMed: 9024720].
  • 10. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. [PubMed: 18565894].
  • 11. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-59. doi: 10.1002/cncr.11105. [PubMed: 12569593].
  • 12. Kang H, O'Connell JB, Leonardi MJ, Maggard MA, McGory ML, Ko CY. Rare tumors of the colon and rectum: A national review. Int J Colorectal Dis. 2007;22(2):183-9. doi: 10.1007/s00384-006-0145-2. [PubMed: 16845516].
  • 13. Younes RN; Grupo de Estudo de Tumores Neuroendocrinos (Getne). Neuroendocrine tumors: A registry of 1,000 patients. Rev Assoc Med Bras (1992). 2008;54(4):305-7. [PubMed: 18719787].
  • 14. Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326(26):1721-6. doi: 10.1056/NEJM199206253262601. [PubMed: 1317506].
  • 15. Zimmer T, Ziegler K, Liehr RM, Stolzel U, Riecken EO, Wiedenmann B. Endosonography of neuroendocrine tumors of the stomach, duodenum, and pancreas. Ann N Y Acad Sci. 1994;733:425-36. doi: 10.1111/j.1749-6632.1994.tb17292.x. [PubMed: 7978891].
  • 16. Yoshida M, Tsukamoto Y, Niwa Y, Goto H, Hase S, Hayakawa T, et al. Endoscopic assessment of invasion of colorectal tumors with a new high-frequency ultrasound probe. Gastrointest Endosc. 1995;41(6):587-92. [PubMed: 7672554].
  • 17. Varas Lorenzo MJ. [Pharmacological treatment of gastroenteropancreatic apudomas with the somatostatin analog SMS 201-995 (octeotride)]. Rev Esp Enferm Dig. 1991;79:95-8. Spanish.
  • 18. Modlin IM, Gilligan CJ, Lawton GP, Tang LH, West AB, Darr U. Gastric carcinoids. The Yale Experience. Arch Surg. 1995;130(3):250-5. discussion 255-6. doi: 10.1001/archsurg.1995.01430030020003. [PubMed: 7887791].
  • 19. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem? Am J Gastroenterol. 2004;99(1):23-32. [PubMed: 14687136].
  • 20. Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: The rapid pace of no progress. Am J Gastroenterol. 2007;102(7):1464-73. doi: 10.1111/j.1572-0241.2007.01185.x. [PubMed: 17391319].
  • 21. Martensson H, Nobin A, Sundler F. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases. Acta Chir Scand. 1983;149(6):607-16. [PubMed: 6650073].
  • 22. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer. 2008;113(1):5-21. doi: 10.1002/cncr.23542. [PubMed: 18473355].
  • 23. Varas Lorenzo MJ. Neuroendocrine tumors: Fascination and infrequency. Rev Esp Enferm Dig. 2009;101(3). doi: 10.4321/s1130-01082009000300006.
  • 24. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117-22. doi: 10.1097/01.sla.0000129342.67174.67. [PubMed: 15213627]. [PubMed Central: PMC1356383].
  • 25. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255-69. doi: 10.1634/theoncologist.2008-0207. [PubMed: 19091780]. [PubMed Central: PMC2901509].
  • 26. Scherubl H. Rectal carcinoids are on the rise: Early detection by screening endoscopy. Endoscopy. 2009;41(2):162-5. doi: 10.1055/s-0028-1119456. [PubMed: 19214898].
  • 27. Kaminski MF, Polkowski M, Regula J. Prevalence and endoscopic features of rectal neuro-endocrine tumours among 50 148 participants of the Polish Colorectal-Cancer Screening Programme. Gut. 2007;56. A310.
  • 28. Mulkeen A, Cha C. Gastric carcinoid. Curr Opin Oncol. 2005;17(1):1-6. [PubMed: 15608504].
  • 29. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC 2nd. A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol. 2009;16(1):51-60. doi: 10.1245/s10434-008-0192-8. [PubMed: 18953609].
  • 30. Massironi S, Sciola V, Spampatti MP, Peracchi M, Conte D. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol. 2009;15(18):2177-83. doi: 10.3748/wjg.15.2177. [PubMed: 19437556]. [PubMed Central: PMC2682231].
  • 31. Varas MJ, García F, Barrios P, Borrell J. [Carcinoid tumors of the digestive system]. Med Clin. 1985;17:715-6. Spanish.
  • 32. Varas MJ. Tumores de los islotes pancreaticos. In: Vilardell F, Rodes J, Malagelada JR, Pajares J M, Perez M, editors. Enfermedades Digestivas. 2. Madrid-Barcelona: Aula Médica; 1998. p. 1516-24. Spanish.
  • 33. Varas Lorenzo MJ, Munoz Agel F, Espinos Perez JC, Bardaji Bofill M. [Digestive carcinoid tumors]. Rev Esp Enferm Dig. 2010;102(9):533-7. Spanish.
  • 34. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89(3):151-60. doi: 10.1002/jso.20179. [PubMed: 15719376].
  • 35. McMullen T, Al-Jahdali A, de Gara C, Ghosh S, McEwan A, Schiller D. A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours. Can J Surg. 2017;60(3):192-7. doi: 10.1503/cjs.007616. [PubMed: 28327275]. [PubMed Central: PMC5453762].
  • 36. Cesar D, Zanatto RM, da Silva MV, Golcalves R, de Mello EL, de Jesus JP. Colon and rectum neuroendocrine tumors: Experience of the National Cancer Institute in Brazil. Arq Bras Cir Dig. 2013;26(1):36-9. [PubMed: 23702868].
  • 37. Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol. 2013;24(12):3040-4. doi: 10.1093/annonc/mdt377. [PubMed: 24050954].
  • 38. Soga J. Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res. 2003;22(4):517-30. [PubMed: 15053292].
  • 39. Ono A, Fujii T, Saito Y, Matsuda T, Lee DT, Gotoda T, et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc. 2003;57(4):583-7. doi: 10.1067/mge.2003.142. [PubMed: 12665777].
  • 40. Martinez-Ares D, Souto-Ruzo J, Varas Lorenzo MJ, Espinos Perez JC, Yanez Lopez J, Abad Belando R, et al. Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig. 2004;96(12):847-55. [PubMed: 15634185].
  • 41. Aguirre A, Cosme A, Bujanda L, Navascues JE, Larburu S, Larzabal M, et al. Diagnosis, treatment and follow-up of gastric carcinoid tumors. Analysis of 14 cases. Rev Esp Enferm Dig. 2011;103(9):493-4. [PubMed: 21951121].
  • 42. Yuksel O. Gastric carcinoid tumors: The problems encountered in diagnosis and treatment. Int J Hematol Oncol. 2013;23(2):104-8. doi: 10.4999/uhod.10034.
  • 43. Varas-Lorenzo MJ, Gornals JB, Munoz F, Loras C, Cruz M, Espinos JC, et al. [Gastric carcinoid tumors: An analysis of 24 cases]. Rev Esp Enferm Dig. 2013;105(10). Spanish. doi: 10.4321/s1130-01082013001000013.
  • 44. Teleky B, Herbst F, Längle F, Neuhold N, Niederle B. The prognosis of rectal carcinoid tumours. Int J Colorectal Dis. 1992;7(1):11-4. doi: 10.1007/bf01647653.
  • 45. Weinstock B, Ward SC, Harpaz N, Warner RR, Itzkowitz S, Kim MK. Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology. 2013;98(3):180-7. doi: 10.1159/000355612. [PubMed: 24080744].
  • 46. Mashimo Y, Matsuda T, Uraoka T, Saito Y, Sano Y, Fu K, et al. Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum. J Gastroenterol Hepatol. 2008;23(2):218-21. doi: 10.1111/j.1440-1746.2008.05313.x. [PubMed: 18289355].
  • 47. Vilallonga R, Espin Basany E, Lopez Cano M, Landolfi S, Armengol Carrasco M. [Neuroendocrine carcinomas of the colon and rectum: One unit experience in six years]. Rev Esp Enferm Dig. 2008;100(1). Spanish. doi: 10.4321/s1130-01082008000100003.
  • 48. Grin A, Streutker CJ. Neuroendocrine tumors of the luminal gastrointestinal tract. Arch Pathol Lab Med. 2015;139(6):750-6. doi: 10.5858/arpa.2014-0130-RA. [PubMed: 26030244].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments